Baba Ramdev's Patanjali Lands In Soup Over Suspicious Transactions: Reports

Following a probe initiated by a federal economic intelligence wing, Patali Ayurved Ltd finds itself under the microscope for a series of that have been flagged as suspicious. Corporate Affairs Ministry has a notice to the, spearheaded by the well-known guru Baba Ramdev demanding explanations for these peculiar financial activities. The inquiry hints at potential breaches of corporate governance norms and raises questions about the possible misallocation of funds.

This scrutiny emerges amidst previous controversies involving Patanjali Ayurved, including instances of non-compliance with tax obligations and questionable refund claims by one of its units. Furthermore, the company has previously been criticized for its advertising practices, where it was found promoting products with unfounded claims of curing serious illnesses, such as cancer. Such actions led to legal repercussions, with the Supreme Court imposing restrictions on the company's advertisement strategies under the Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954.

Adding to the company's woes, Patanjali Ayurved's financial conduct has been deemed "abnormal and dubious" by unnamed officials, as per a Bloomberg report. This has propelled the Ministry to delve deeper into the company's financial transactions, scrutinizing them for any signs of irregularity that may hint at a deviation from established corporate governance protocols or indicate fund diversion. These developments mark yet another chapter in the company's history of regulatory challenges.

Despite its status as a privately held entity, the controversy surrounding Patanjali Ayurved has had a ripple effect on its publicly listed unit, Patanjali Foods Ltd. The shadow cast by these investigations has seen the unit's stock prices tumble nearly 10% in the current month, reflecting investor apprehensions about the ongoing scrutiny and its potential implications.